Laboratory-based surveillance of Pneumocystis jirovecii pneumonia in South Africa, 2006–2010

References

• Maskell NA, Waine DJ, Lindley A., et al. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax. 2003;58(7):594–7.10.1136/thorax.58.7.594
   PubMed Web of Science ®Google Scholar
• Lu JJ, Lee CH. Pneumocystis pneumonia. J Formos Med Assoc. 2008;107(11):830–42.10.1016/S0929-6646(08)60199-0
   PubMed Web of Science ®Google Scholar
• Morris A, Lundgren JD, Masur H, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 2004;10(10):1713–20.10.3201/eid1010.030985
   PubMed Web of Science ®Google Scholar
• Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997–1998. Int J Tuberc Lung Dis. 2002;6(1):55–63.
   PubMed Web of Science ®Google Scholar
• van Oosterhout JJ, Laufer MK, Perez MA, et al. Pneumocystis pneumonia in HIV-positive Adults, Malawi. Emerg Infect Dis. 2007;13(2):325–8.10.3201/eid1302.060462
   PubMed Web of Science ®Google Scholar
• Zar HJ, Dechaboon A, Hanslo D, et al. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus. Pediatr Infect Dis J. 2000;19(7):603–7.10.1097/00006454-200007000-00004
   PubMed Web of Science ®Google Scholar
• Aderaye G, Bruchfeld J, Aseffa G, et al. Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia. Scand J Infect Dis. 2007;39(11–12):1045–53.10.1080/00365540701474508
   PubMed Web of Science ®Google Scholar
• Chakaya JM, Bii C, Ng’ang’a L, et al. Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya. East Afr Med J. 2003;80(1):30–5.
   PubMedGoogle Scholar
• Mahomed AG, Murray J, Klempman S, et al. Pneumocystis carinii pneumonia in HIV infected patients from South Africa. East Afr Med J 1999;76(2):80–4.
   PubMed Web of Science ®Google Scholar
• Aderaye G, Bruchfeld J, Olsson M, et al. Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia. AIDS. 2003;17(3):435–40.10.1097/00002030-200302140-00018
   PubMed Web of Science ®Google Scholar
• Dini L, du Plessis M, Frean J, et al. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol. 2010;48(6):2016–21.10.1128/JCM.02004-09
   PubMed Web of Science ®Google Scholar
• Govender N, Quan V, Prentice E, et al. GERMS-SA: a national South African surveillance network for bacterial and fungal diseases. Communicable Diseases Surveillance Bulletin. Johannesburg: National Institute for Communicable Diseases of the National Health Laboratory Service; 2006 May. Available from: http://www.nic.ac.za/assets/files/CommDisBullMay06.pdf.
   Google Scholar
• NHLS - About Us. National Health Laboratory Service of South Africa. 2012. Available from: http://www.nhls.ac.za/about.us.
   Google Scholar
• Burgard M, Blanche S, Jasseron C, et al. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. J Pediatr. 2012;160(1):60–66.e1.10.1016/j.jpeds.2011.06.053
   PubMed Web of Science ®Google Scholar
• Metersky ML, Aslenzadeh J, Stelmach P. A comparison of induced and expectorated sputum for the diagnosis of Pneumocystis carinii pneumonia. CHEST J. 1998;113(6):1555–9.10.1378/chest.113.6.1555
   PubMed Web of Science ®Google Scholar
• UNAIDS Global report on the AIDS epidemic 2010. Geneva: UNAIDS; 2010. Available from: http://www.unaids.org/globalreport.
   Google Scholar
• Madhi SA, Cutland C, Ismail K, et al. Ineffectiveness of trimethoprim‐sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in african children with Pneumocystis carinii pneumonia. Clin Infect Dis. 2002;35(9):1120–6.10.1086/cid.2002.35.issue-9
   PubMed Web of Science ®Google Scholar
• Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet. 2002;360(9338):985–90.10.1016/S0140-6736(02)11082-8
   PubMed Web of Science ®Google Scholar
• Graham SM, Mtitimila EI, Kamanga HS, et al. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet. 2000;355(9201):369–73.10.1016/S0140-6736(98)11074-7
   PubMed Web of Science ®Google Scholar
• Ikeogu MO, Wolf B, Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child. 1997;76(2):124–8.10.1136/adc.76.2.124
   PubMed Web of Science ®Google Scholar
• Graham SM, Gibb DM. HIV disease and respiratory infection in children. Br Med Bull. 2002;61:133–50.10.1093/bmb/61.1.133
   PubMed Web of Science ®Google Scholar
• Gibb DM, Davison CF, Holland FJ, et al. Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles. Arch Dis Child. 1994;70(3):241–4.10.1136/adc.70.3.241
   PubMed Web of Science ®Google Scholar
• Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis. 2003;36(1):70–8.10.1086/cid.2003.36.issue-1
   PubMed Web of Science ®Google Scholar
• Preidis GA, McCollum ED, Mwansambo C, et al. Pneumonia and malnutrition are highly predictive of mortality among African children hospitalized with human immunodeficiency virus infection or exposure in the era of antiretroviral therapy. J Pediatr. 2011;159(3):484–9.10.1016/j.jpeds.2011.02.033
   PubMed Web of Science ®Google Scholar
• Wang HW, Lin CC, Kuo CF, et al. Mortality predictors of Pneumocystis jirovecii pneumonia in human immunodeficiency virus-infected patients at presentation: experience in a tertiary care hospital of northern Taiwan. J Microbiol Immunol Infect. 2011;44(4):274–81.10.1016/j.jmii.2010.08.006
   PubMedGoogle Scholar
• Ledergerber B, Egger M, Erard V, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy. JAMA. 1999;282(23):2220–6.10.1001/jama.282.23.2220
   PubMed Web of Science ®Google Scholar
• Manosuthi W, Chaovavanich A, Tansuphaswadikul S, et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Infect. 2007;55(5):464–9.10.1016/j.jinf.2007.07.002
   PubMed Web of Science ®Google Scholar
• Egger M, May M, Chêne G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119–29.10.1016/S0140-6736(02)09411-4
   PubMed Web of Science ®Google Scholar
• Wislez M, Bergot E, Antoine M, et al. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 2001;164(5):847–51.10.1164/ajrccm.164.5.2007034
   PubMed Web of Science ®Google Scholar
• Huang L, Morris A, Limper AH, et al. An official ATS workshop summary: recent advances and future directions in Pneumocystis pneumonia (PCP). Proc Am Thorac Soc. 2006;3(8):655–64.10.1513/pats.200602-015MS
   PubMedGoogle Scholar
• Simonds RJ, Lindegren ML, Thomas P, et al. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. N Engl J Med. 1995;332(12):786–90.10.1056/NEJM199503233321206
   PubMed Web of Science ®Google Scholar
• Nielsen SD, Jeppesen DL, Kolte L, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood. 2001;98(2):398–404.10.1182/blood.V98.2.398
   PubMed Web of Science ®Google Scholar
• McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369(9571):1440–51.10.1016/S0140-6736(07)60670-9
   PubMed Web of Science ®Google Scholar
• Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364(9448):1865–71.10.1016/S0140-6736(04)17442-4
   PubMed Web of Science ®Google Scholar
• Badri M, Ehrlich R, Wood R, et al. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS. 2001;15(9):1143–8.10.1097/00002030-200106150-00009
   PubMed Web of Science ®Google Scholar
• Calderón EJ, Varela JM, Medrano FJ, et al. Epidemiology of Pneumocystis carinii pneumonia in southern Spain. Clin Microbiol Infect. 2004;10(7):673–6.10.1111/j.1469-0691.2004.00921.x
   PubMed Web of Science ®Google Scholar
• Harris JR, Marston BJ, Sangrujee N, et al. Cost-effectiveness analysis of diagnostic options for Pneumocystis pneumonia (PCP). PLoS ONE. 2011;6(8):e23158.10.1371/journal.pone.0023158
   PubMed Web of Science ®Google Scholar
• Meiring ST, Quan VC, Cohen C, et al. A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005–2007. AIDS. 2012 Nov 28;26(18):2307–14.10.1097/QAD.0b013e3283570567
   PubMed Web of Science ®Google Scholar
• Group for Enteric, Respiratory and Meningeal disease Surveillance in South Africa. GERMS-SA Annual Report 2011. National Institute for Communicable Diseases; 2011. Available from: http://www.nicd.ac.za/assets/files/2011%20GERMS-SA%20Annual%20report%20Final.pdf.
   Google Scholar